The randomized PRO-TAVI trial showed that in patients with coronary artery disease undergoing transcatheter aortic valve ...

Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of ...

Artificial intelligence based music therapy intervention in cancer patients undergoing chemotherapy in oncology day care (MUSICC). Exploring social determinants of health and immunotherapy utilization ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk ...

A Nature Medicine study found that healthy Australian adults were widely exposed to plastic-associated chemicals, with ...

The 58 participant, randomized, double-blind, placebo-controlled study was led by Edmarie Guzmán-Vélez, PhD, formerly an Assistant Professor in the Department of Psychiatry and the McCance Center for ...